Barclays Remains a Buy on Elevance Health (ELV)
In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Elevance Health Inc. stock underperforms Tuesday when compared to competitors
Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.
Forbes18 天
Elevance Health Bolsters Anthem Portfolio, Closes Indiana University Health Plans Deal
Elevance Health closed its acquisition of Indiana University Health Plans, adding to its growing portfolio of Anthem Blue Cross and Blue Shield operations. The company Tuesday said IU Health is ...
Ibj.com17 天
Elevance completes IU Health Plans acquisition
Elevance is Indiana’s largest public company, with revenue of $171.3 billion in 2023. As of the end of September, its medical membership totaled about 45.8 million. The IU Health Plans deal was ...